Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
21.00    0.00 (0.00%)
Bid:
18.00
Ask:
24.00
Spread: 6.00 (33.333%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Trading Update

3 Feb 2020 07:00

RNS Number : 6618B
Pennant International Group PLC
03 February 2020
 

 

FOR IMMEDIATE RELEASE 3 February 2020 

PENNANT INTERNATIONAL GROUP PLC

 

Trading Update

 

 

Pennant International Group plc ("Pennant", the "Group", or the "Company"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, announces the following trading update in respect of its financial year ending 31 December 2019 ("FY2019"). The Group's audited results for FY2019 are scheduled to be released on 23 March 2020.

 

Preliminary unaudited assessment of the Group's trading for FY2019 indicates that Pennant will report:

 

·; Revenues of circa £20 million;

·; Underlying earnings before interest, taxation and amortisation (EBITA) of circa £1.6 million;

·; Underlying earnings before interest, taxation, depreciation and amortisation (EBITDA) of circa £2.4 million;

·; Net debt at year-end of £2.2 million;

·; Three-year order book at year-end of £33 million of which circa £16 million is scheduled for delivery in 2020.

 

Underlying EBITA is stated after the add-back of a one-off restructuring expense and a charge relating to the impairment of the Group's freehold property portfolio (amounting to £0.7 million and £0.8 million respectively) both described in more detail below.

 

Impairment of freehold properties

 

In order to gear up for major contracts, the Group invested over £3 million in freehold property. The properties acquired are currently being utilised on the Qatar programme and on the helicopter maintenance trainer contract announced on 31 October 2019 and are necessary for the further expansion of the business.

 

Following a revaluation for the purposes of the annual accounts, it has become apparent that, due to the general softening of the commercial property market both locally and more broadly, certain of the properties are currently overvalued in the Company's books. While the net effect of the revaluation across Pennant's freehold portfolio is a reduction of £0.4 million (being an impairment of £0.8 million against certain properties and an increase in value of £0.4 million against others), due to applicable accounting standards the Group is required to expense the gross amount of the impairment (£0.8 million), which is regarded as non-underlying, with the upwards revaluations being credited to reserves.

 

Restructuring expense

 

As outlined in its announcement of 2 May 2019, the Group has been implementing a wide-ranging cost reduction exercise and various roles have been removed from the business. The aggregate cost associated with terminations of employment resulting from this exercise is £0.7 million which is regarded as a non-underlying expense.

 

It is anticipated that this programme will realise gross annualised savings of over £1 million. Taking into account new roles and capabilities implemented in the revised structure, the net annualised cost saving will be circa £0.6 million.

 

Strategy and Outlook

 

The Group continues to focus on its strategic objective of increasing the proportion of its revenues which derive from software and services, particularly those of a recurring nature.

 

Recent steps taken include an agreement to acquire Absolute Data Group (announced on 21 January 2020) which will form part of an enlarged, enhanced 'Integrated Logistics Support' offering as well as providing an increased presence in Pennant's target growth markets of North America and Australasia.

 

Pennant is actively considering other strategic opportunities to partner with or acquire complementary businesses and will continue to invest in developing its product range and its ability to deliver complementary services.

 

With a contracted order book of £33 million scheduled for delivery over the next three years, together with a sizeable pipeline of single-source opportunities, the Board remains confident of future prospects and of building and delivering long-term shareholder value.

 

 

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Chris Savidge

+44 (0) 117 945 3470

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKBBNDBKBCBK
Date   Source Headline
4th Jun 20267:00 amRNS-RLaunch of Auxilium Phase 3
20th May 20263:18 pmRNSHolding(s) in Company
19th May 20267:20 amRNS-R1st conversion services contract & Siemens update
14th May 20267:00 amRNSDirector dealing
13th May 20267:00 amRNSGrant of Options
11th May 20267:00 amRNSTraining Systems Contract Win
8th May 202611:56 amRNSResult of AGM
21st Apr 20262:05 pmRNSHolding(s) in Company
1st Apr 20262:54 pmRNSNotice of AGM & Posting of Accounts
31st Mar 20265:00 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSIssue of Equity
23rd Mar 20267:00 amRNSFinal Results & Notice of Investor Presentation
2nd Feb 20267:00 amRNSTraining Systems Contract Win
19th Jan 20267:00 amRNSTrading & Strategy Update, Notice of Results
15th Jan 20267:00 amRNSDirectorate change
12th Dec 20253:34 pmRNSDirector Dealing
1st Dec 20251:36 pmRNSDirector Dealing
27th Nov 20259:40 amRNSHolding(s) in Company
25th Nov 202512:40 pmRNSGenFly Contract Award - valued at up to £5.75m
24th Oct 202511:15 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSShareholder Loan
8th Oct 202510:36 amRNSContract wins
1st Oct 20259:39 amRNSTotal Voting Rights
25th Sep 202512:59 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSSubscription update and closing & TVR
16th Sep 20257:01 amRNSProposed Underwritten Subscription to raise £1.25m
16th Sep 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Aug 20257:00 amRNSChange of Adviser
11th Aug 20253:01 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSTrading Update & Notice of Results
14th Jul 20257:00 amRNSGlobal Partner Appointed & Auxilium Presentation
3rd Jul 20257:00 amRNSBusiness Update
6th Jun 20251:08 pmRNSResult of AGM
8th May 202512:30 pmRNSNotice of AGM & Posting of Accounts
24th Apr 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
9th Apr 20257:00 amRNSGenFly Contract Update
8th Apr 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
7th Apr 20257:00 amRNSProperty Disposal Programme Update
11th Mar 20252:25 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSProperty Disposal Programme Update
3rd Feb 20251:41 pmRNSDirector Dealings
16th Dec 202410:49 amRNSHolding(s) in Company
12th Dec 20247:00 amRNSAward of Options
10th Dec 20247:00 amRNSTrading Statement, Business Update & Investor Pres
20th Nov 20247:00 amRNSAppointment of CFO
14th Nov 20242:47 pmRNSHolding(s) in Company
6th Nov 20244:34 pmRNSHolding(s) in Company
23rd Oct 20243:56 pmRNSContracts Update
22nd Oct 20245:55 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.